Search This Blog

Monday, November 11, 2019

FibroGen EPS misses by $0.03, beats on revenue

FibroGen (NASDAQ:FGEN): Q3 GAAP EPS of -$0.57 misses by $0.03.
Revenue of $33.17M (+14.3% Y/Y) beats by $1.56M.
Shares +0.17%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)